Abstract
Schistosome granulomas make substance P (SP). CP96,345 is a nonpeptide SP receptor antagonist active in vivo. Granulomas that form in the presence of SP receptor blockade produce little IgM as compared to normal lesions. The objective of this study was to determine how CP96,345 modulates granuloma IgM production. Schistosome ova were embolized to the lungs of infected mice to induce granulomas of synchronous age. Animals received CP96,345 (50 mg/kg/day) for 4 days following egg embolization. Then granulomas were isolated from tissue and dispersed into single-cell preparations. The dispersed granuloma cells were cultured in vitro to measure IgM and cytokine secretion. Also, granuloma B cells were studied using an IgM ELISPOT assay and flow cytometry. As expected, mice treated with CP96,345 formed granulomas that secreted little IgM. Granulomas from CP96,345-treated mice, as compared to buffer-treated animals, contained few IgM-secreting B lymphocytes, but had appropriate numbers of B cells expressing surface IgM. Also decreased was the capacity of the granulomas to make IFN-gamma, IL-4, IL-5 and IL-6. CP96,345 treatment did not affect splenocyte IgM or cytokine synthesis. These data suggest that CP96,345 inhibits granuloma IgM s...Continue Reading
References
Jul 7, 1992·European Journal of Pharmacology·A NagahisaH J Hess
Mar 1, 1992·British Journal of Pharmacology·F LembeckA Nagahisa
Jun 1, 1992·European Journal of Immunology·C Phillips, G G Klaus
Aug 1, 1991·Immunology and Cell Biology·A EglezosR D Helme
Jan 25, 1991·Science·R M SniderR W Spencer
Sep 1, 1991·Journal of Neuroimmunology·G A CookJ V Weinstock
Jan 1, 1986·Pharmacology·M Roch-ArveillerJ P Giroud
Jun 1, 1987·Immunology and Cell Biology·R D HelmeC S Hosking
Sep 2, 1988·Science·M LotzD A Carson
Jan 1, 1988·Annals of the New York Academy of Sciences·E S KimballJ L Vaught
Jan 1, 1993·Neuropeptides·S A Krumins, C A Broomfield
Jan 26, 1993·European Journal of Pharmacology·T SakamotoK F Chung
May 1, 1993·The Journal of Experimental Medicine·E W GreenoC F Moldow
May 12, 1993·European Journal of Pharmacology·M MuraiT Fujii
Jun 1, 1993·Biulleten' eksperimental'noĭ biologii i meditsiny·N A KlimenkoE D Gol'dberg
Jul 1, 1993·The Journal of Clinical Investigation·J SolwayA Garland
Jan 1, 1993·Immunology Today·C M Snapper, J J Mond
Mar 1, 1996·Journal of Pediatric Endocrinology & Metabolism : JPEM·A Cox, G W Duff
Aug 1, 1956·Proceedings of the Society for Experimental Biology and Medicine·C M COKER, F LICHTENBERG
Citations
Mar 1, 2000·Journal of Neuroimmunology·P G Kennedy
Jun 18, 1997·Regulatory Peptides·C A Maggi
Jun 26, 2008·The Journal of Parasitology·Armandina GarzaPrema Robinson
Jun 23, 1999·Journal of Neuroimmunology·G SantoniM Piccoli
Jan 5, 2001·Expert Opinion on Investigational Drugs·S Brunelleschi
May 8, 1998·Neuropeptides·L Quartara, C A Maggi
Nov 1, 2001·Respiratory Research·B N Lambrecht
Jun 13, 2006·Pharmacology & Therapeutics·Erika PintérJános Szolcsányi
Apr 17, 2007·Experimental Parasitology·Hong-mei MoYong-long Li
Mar 5, 2002·Clinical and Diagnostic Laboratory Immunology·Ioana M SoneaJames A Harp
Dec 16, 2016·PloS One·Rajeev RanjanJonathan Arzt
Apr 9, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A M BlumJ V Weinstock
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·P G KennedyJ M Burke
Jan 27, 1998·Neurology·A G DrooganS A Hawkins